Trial 1.
Amplifica’s AMP-303 Study Unveils New Hope for Hair Loss Treatments - Amplifica
First-in-Human Trial Demonstrates Promising Results for the Treatment of Androgenetic Alopecia San Diego, CA, September 30, 2024 - Amplifica Holdings Group Inc. (“Amplifica”), a privately held clinical-stage biopharmaceutical company, today announced results from its first-in-human trial of...
amplificabio.com